NFE2L2 and esophageal cancer: As in previous reports, a high frequency of mutations were found in TP53, NFE2L2, and CDKN2A genes in esophageal cancer based on our deep sequencing results and suggest that these gene mutations could be established as contributors to esophageal cancer tumorigenesis [12, 13, 22, 23].